# allphamed PHARBIL Arzneimittel GmbH – FDA Inspection, Jul 12, 2019

Source: https://www.keypedia.com/records/fda_inspections/allphamed-pharbil-arzneimittel-gmbh/7dc2a2ba-7200-4939-b38c-997d75744ad5
Source feed: FDA_Inspections

> FDA inspection 1096510 of allphamed PHARBIL Arzneimittel GmbH, July 12, 2019. Classification: Voluntary Action Indicated (VAI). 7 citations under 21 CFR part 211. Form 483 issued. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1096510
- Company Name: allphamed PHARBIL Arzneimittel GmbH
- Inspection Date: 2019-07-12
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Generic Drug Evaluation
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 7

## Related Documents

- FDA Inspection 1305638 - 2024-11-19
- FDA Inspection 1140527 - 2020-10-01
- FDA Inspection 1030230 - 2017-09-29
- FDA Inspection 935795 - 2015-07-10
- FDA Inspection 894011 - 2014-09-05

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/christopher-r-czajka/42defbf3-ea06-4090-8d51-7da2b07d9e84)

Company: https://www.keypedia.com/companies/allphamed-pharbil-arzneimittel-gmbh/5f5dbcea-8898-466c-a71e-ac9037437465

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8